Coronary bypass surgery for patients with chronic poor preoperative left ventricular function (EF < 30%): 5-year follow-up

Heart Lung and Circulation

Volumn 15, Issue 2, 2006, Pages 130-136

  Tan, Jeremy ^a   Kejriwal, Nand ^a   Vasudevan, Arvind ^a   Santa Maria, Peter L ^a   Alvarez, John M ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

CABG; Function; Poor; Surgery; Ventricular

Indexed keywords

THALLIUM;

ADULT; ANGINA PECTORIS; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART SCINTISCANNING; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL TIME; TREATMENT INDICATION;

EID: 33646144426     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.09.002     Document Type: Article

References (34)

1. Marwick T. The viable myocardium: epidemiology, detection and clinical implications. Lancet 1998;351:815-8.
2. Isom WO, Spencer F, Glassman E, Dembrow JM, Pasternick BS. Long-term survival following coronary bypass surgery in patients with significant impairment of left ventricular function. Circulation 1975;51(Suppl.I):141-7.
3. Hung J, Kelly DT, Baird DK, Hendel PN, Leckie BD, Grant AF, et al. Aorta coronary bypass grafting in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 1980;79:718-23.
4. O'Connor CM, Velazquez EF, Gardner LH, Smith PK, Newman MF, Gandolfo KP, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with alchemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank.). Am J Cardiol 2002;90:101-7.
5. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta analysis. J Am Coll Cardiol 2002;39:1151-8.
6. Zimmerman R, Mall G, Rauch B, Zimmer G, Gabel M, Zehelin J, et al. Residual 201-Thallium activity in irreversible defects as a marker of myocardial viability: clinicopathological study. Circulation 1995;91:1016-21.
7. Mickleborough LL, Carson S, Tamariz M, Ivanov J. Results of revascularisation in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 2000;119:550-7.
8. Segall G. Assessment of myocardial viability by positron emission tomography. Nucl Med Commun 2002;23:323-30.
9. Elefteriades JA, Tolis G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-7.
10. Alvarez JM, Shardey GC, Goldstein J, Cooke J, Harper RW. Orthodox CABG surgery: the gold standard in surgical coronary artery disease intervention. Asia Pac Heart J 1999;8:148-53.
11. Hewitt TD, Santa Maria PL, Alvarez JM. Cardiac surgery in Australian octogenarians: 1996-2001. Aust N Z J Surg 2003;73:749-54.
12. Alvarez JM, Chatwin C, Fahrer C. The prevention of anuric renal failure postcardiac surgery in at risk patients by the prophylactic use of iv mannitol and normal saline. Heart Lung Circ 2000;9:74-7.
13. Chan RKM, Raman J, Lee KJ, Rosalion A, Hicks RJ, Pornvilavan S, et al. Prediction of outcome after revascularisation in patients with poor left ventricular function. Ann Thorac Surg 1996;61:1428-34.
14. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJT. Failure to improve left ventricular function after coronary revascularisation for ischaemic cardiomyopathy is not associated with a worse outcome. Circulation 1999,12:1298-304.
15. Baumgartner H, Porenta G, Lau YK, Wutts M, Klaar V, Mehraby M, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998;32:1701-8.
16. Vanoverschelde JJ, Gerber BL, D'Hondt AM, De Kock M, Dion R, Wijns W, et al. Preoperative selection of patients with severely impaired left ventricular dysfunction for coronary revascularisation. Circulation 1995;92:37-44.
17. Siebelink HJ, Blanksma PK, Crijns HJGM, Bax JJ, van Boven AJ, Kingma T, et al. No difference in cardiac event free survival between positron emission tomography guided and single photon emission computed tomography guided patient management. J Am Coll Cardiol 2001;37:81-8.
18. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function. Circulation 1983;68: 785-95.
19. Coles JG, Del Campo C, Ahmed SN, Corpus R, MacDonald AC, Goldbach MM, et al. Improved long term survival following myocardial revascularisation in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 1981;80:846-50.
20. Lansmann SL, Cohen M, Galla JD, Machac J, Quintana CS, Ergin A, et al. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long-term follow-up. Ann Thorac Surg 1993;56:480-6.
21. Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE, Goldman BS, et al. Coronary artery bypass grafting in patients with poor ventricular function. Ann Thorac Surg 1992;103:1083-92.
22. Milano CA, White WD, Smith LR, Jones RH, Lowe JE, Smith PK, et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993;56:487-93.
23. Kaul TK, Agnihothri AK, Fields BL, Riggins LS, Wyatt DA, Jones CR. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 1996;111:1001-12.
24. Langenburg SE, Buchanan SA, Blackbourne LH, Scheri RP, Sinclair KN, Martinez J, et al. Predicting survival after coronary revascularisation for ischaemic cardiomyopathy. Ann Thorac Surg 1995;60:1193-7.
25. Louagie Y, Jamart J, Buche M, Eucher P, Haxhe JP, Lhommei J, et al. Myocardial revascularisation for severe left ventricular dysfunction. Factors influencing early and late survival. Cardiovasc Surg 1996;4:607-16.
26. Cimochowski GE, Harostock MD, Foldes PJ. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg 1997;113:655-66.
27. Luciani GB, Montalbano G, Casali G, Mazzucco A. Predicting long-term functional results after myocardial revascularisation in alchemic cardiomyopathy. J Thorac Cardiovasc Surg 2000;120:478-89.
28. Antunes PE, Ferrao de Oliveira JM, Antunes MJ. Coronary surgery with noncardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long-term results. Heart 2003;89:427-31.
29. Shapira I, Isakov A, Yakirevich V, Topilsky M. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 1995;108:1546-50.
30. Bouchart F, Tabley A, Litzler PY, Haas-Hubscher C, Bessou JP, Soyer R. Myocardial revascularisation in patients with severe alchemic left ventricular dysfunction. Long-term follow-up in 141 patients. Eur J Cardiothorac Surg 2001;20:1157-62.
31. Argenziano M, Spotnitz HM, Whang W, Bigger Jr JT, Parides M, Rose EA. Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction. Analysis of the coronary artery bypass grafting Patch trial database. Circulation 1999;(Suppl.II):119-24.
32. Newman MAJ, Kolybaba M, Alvarez JM. Off-pump CABG: Five-year follow-up of 350 consecutive cases. Heart Lung Circ 2003;12:157-61.
33. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM. Acute coronary findings at autopsy in heart failure patients with sudden death. Circulation 2000;102: 611-5.
34. PROGRESS Collaborative Group. Randomised trial of a perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.